When comparing bioscaffolds preserved with one additive 7 and 14 days after thawing, those preserved with DMSO 10% showed the highest viable cell number in proliferation ((Table 1 and Fig. 3A,B).
Fewer mutations were detected in pediatric nodal marginal zone lymphoma, with 14 single-nucleotide variants observed in genes involved in cellular adhesion, cytokine regulatory elements, and cellular proliferation (Table 3).
A total of 46 non-synonymous somatic mutations affecting 44 different genes were identified, including both missense mutations and nonsense mutations.3 In pediatric-type follicular lymphoma, we identified 32 single-nucleotide variants in genes involved in transcription, intracellular signaling, and cell proliferation (Table 2).
Furthermore the halfbodies, but not the parental anti-cMet antibody, inhibited tumor cell proliferation (Table S2).
The unique HIV integrations in our participants were enriched in genes controlling cell proliferation (table S2), and were overrepresented in the hallmark cancer GO terms (23 25) when compared to integrations from the Jurkat cell dataset (51.29% versus 41.96%; P = 0.0001).
PKO-βTag islets showed a statistically significant 2.2 fold reduction in beta-cell proliferation (Table 1).
To compare PRE and SEN cells, we made PRE cells quiescent by culturing to confluence, thereby controlling for effects of cell proliferation (Table 1).
The transcripts shared by HuR and CUGBP1 are enriched in factors linked with cell cycle and post-transcriptional regulation of gene expression, while those shared by CUGBP1 and Pum1 are associated with cell proliferation (Table S4).
As relates to the other experiments in this study, differences were observed in expression of genes involved cell cycle control and proliferation (Table 1), mitochondrial function (Table 2), oxidative stress and oxidative defense (Table 3), and apoptosis (Table 4).
CD46 coupling with CD3 activates the transcription factor ubiquitously transcribed tetratricopeptide (UTX) [36] that interacts with signal transducer and activator of transcription 1 (STAT1) [37] [39] both translocate to the nucleus to activate proliferation (Table 2).
It is not related to an alteration of cell proliferation (Table S1) and may reflect an inefficient knock-down of CaMKIα expression by the siRNA used in the screen.
